PMC:7048180 / 10749-10945 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T53","span":{"begin":63,"end":71},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"We expect more cross-reactive antibodies against 2019-nCoV and SARS-CoV or other coronaviruses to be identified soon, facilitating the development of effective antiviral therapeutics and vaccines."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":160,"end":169},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"We expect more cross-reactive antibodies against 2019-nCoV and SARS-CoV or other coronaviruses to be identified soon, facilitating the development of effective antiviral therapeutics and vaccines."}

{"project":"LitCovid-sentences","denotations":[{"id":"T65","span":{"begin":0,"end":196},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We expect more cross-reactive antibodies against 2019-nCoV and SARS-CoV or other coronaviruses to be identified soon, facilitating the development of effective antiviral therapeutics and vaccines."}

{"project":"LitCovid-PubTator","denotations":[{"id":"366","span":{"begin":49,"end":58},"obj":"Species"},{"id":"367","span":{"begin":63,"end":71},"obj":"Species"},{"id":"368","span":{"begin":81,"end":94},"obj":"Species"}],"attributes":[{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"Tax:2697049"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"Tax:694009"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We expect more cross-reactive antibodies against 2019-nCoV and SARS-CoV or other coronaviruses to be identified soon, facilitating the development of effective antiviral therapeutics and vaccines."}